Catalog |
name |
Description |
price |
R-M-657 |
Amyloid β-Protein (1-6) trifluoroacetate salt |
Amyloid β-Protein (1-6) trifluoroacetate salt,CAS:214550-64-8 from ruixi.It can be applied to Alzheimer Disease. |
price> |
R-M-658 |
Acetyl-Amyloid β-Protein (1-6) amide trifluoroacetate salt |
Acety-Amyloid β-Protein (1-6) amide trifluoroacetate salt,CAS :903883-22-7 from ruixi.It can be applied to Alzheimer Disease. |
price> |
R-M-660 |
Amyloid β-Protein (1-15) trifluoroacetate salt |
Amyloid β-Protein (1-15) trifluoroacetate salt,CAS : 183745-81-5 from ruixi.Aβ (1-15) was used in a study investigating the presence of conformational epitope/s (mimotope/s) on fibrillar amyloid β-protein (1-42). The N-terminal Aβ fragments Aβ1-14, Aβ1-15, and Aβ1-16 are elevated in cell media and in CSF in response to γ-secretase inhibitor treatment. The fragments can serve as biomarkers in clinical studies of the effect of such inhibitors. |
price> |
R-M-769 |
Amyloid β-Protein (1-40) (HFIP-treated) |
Amyloid β-Protein (1-40) (HFIP-treated),CAS :131438-79-4 is a Amyloid peptide.It can be used Alzheimer Disease. |
price> |
R-M-773 |
Amyloid β-Protein (1-39) trifluoroacetate salt |
Amyloid β-Protein (1-39) trifluoroacetate salt,CAS:115427-62-8 from ruixi.It can be used Alzheimer Disease. |
price> |
R-M-788 |
Chlorotoxin trifluoroacetate salt |
Chlorotoxin trifluoroacetate salt,CAS :163515-35-3 from ruixi.As chlorotoxin targets cancer cells, it was conjugated to drugs as cisplatin or dyes. |
price> |
R-M-869 |
Humanin (human) trifluoroacetate salt |
Humanin (HN) is a polypeptide suppressing neuronal cell death induced by several familial Alzheimer disease genes and by amyloid β-protein (1-43) (human). It has been shown that amyloid β-protein (1-40) and amyloid β-protein (1-42) secretion is not affected by humanin in F11 cells expressing the familial Alzheimer disease gene K595N/M596L-APP. |
price> |
R-M-1450 |
Beta Amyloid [25-35] Peptide,Cas:131602-53-4 |
Beta-amyloid production results from cleavage in the extracellular domain of APP by the beta-secretase (BACE1), which results in the production of the APP C-terminal fragment C99. This fragment is further cleaved by the gamma-secretase at residues 40-42 to produce beta-amyloid 40 and 42 peptides. Beta-amyloid aggregation and neuritic plaque formation are pathologic hallmarks of Alzheimer disease. This peptide corresponds to the human beta-amyloid 25-35 peptide, which induces apoptosis in cells. |
price> |
R-M-1451 |
Beta Amyloid [1-42] Peptide (Rat),Cas:166090-74-0 |
Beta Amyloid [1-42] Peptide (Rat) is a rat form of the predominant amyloid β-peptide found in plaques associated with Alzheimer disease. Leads to a large shift in the bax/bcl-2 ratio in favour of pro-apoptotic bax. |
price> |
R-M-1453 |
Beta Amyloid [1-40] Peptide (Rat),Cas:144409-98-3 |
Beta Amyloid (1-40), rat is a form of the amyloid β-peptide found in plaques associated with Alzheimer disease. It has both neurotrophic and neurotoxic effects and may affect synaptic plasticity. |
price> |